189 related articles for article (PubMed ID: 32937437)
1. Identification of human CD4
Nelson MH; Knochelmann HM; Bailey SR; Huff LW; Bowers JS; Majchrzak-Kuligowska K; Wyatt MM; Rubinstein MP; Mehrotra S; Nishimura MI; Armeson KE; Giresi PG; Zilliox MJ; Broxmeyer HE; Paulos CM
Sci Adv; 2020 Jul; 6(27):. PubMed ID: 32937437
[TBL] [Abstract][Full Text] [Related]
2. Distinctive CD26 Expression on CD4 T-Cell Subsets.
Cordero OJ; Rafael-Vidal C; Varela-Calviño R; Calviño-Sampedro C; Malvar-Fernández B; García S; Viñuela JE; Pego-Reigosa JM
Biomolecules; 2021 Oct; 11(10):. PubMed ID: 34680079
[TBL] [Abstract][Full Text] [Related]
3. Human CD26
Bailey SR; Nelson MH; Majchrzak K; Bowers JS; Wyatt MM; Smith AS; Neal LR; Shirai K; Carpenito C; June CH; Zilliox MJ; Paulos CM
Nat Commun; 2017 Dec; 8(1):1961. PubMed ID: 29213079
[TBL] [Abstract][Full Text] [Related]
4. Human Th17 cells express high levels of enzymatically active dipeptidylpeptidase IV (CD26).
Bengsch B; Seigel B; Flecken T; Wolanski J; Blum HE; Thimme R
J Immunol; 2012 Jun; 188(11):5438-47. PubMed ID: 22539793
[TBL] [Abstract][Full Text] [Related]
5. A novel chimeric antigen receptor redirecting T-cell specificity towards CD26
Zhou S; Li W; Xiao Y; Zhu X; Zhong Z; Li Q; Cheng F; Zou P; You Y; Zhu X
Leukemia; 2021 Jan; 35(1):119-129. PubMed ID: 32317776
[TBL] [Abstract][Full Text] [Related]
6. Selective refueling of CAR T cells using ADA1 and CD26 boosts antitumor immunity.
Hu Y; Sarkar A; Song K; Michael S; Hook M; Wang R; Heczey A; Song X
Cell Rep Med; 2024 May; 5(5):101530. PubMed ID: 38688275
[TBL] [Abstract][Full Text] [Related]
7. Cell surface characterization of T lymphocytes and allergen-specific T cell clones: correlation of CD26 expression with T(H1) subsets.
Willheim M; Ebner C; Baier K; Kern W; Schrattbauer K; Thien R; Kraft D; Breiteneder H; Reinisch W; Scheiner O
J Allergy Clin Immunol; 1997 Sep; 100(3):348-55. PubMed ID: 9314347
[TBL] [Abstract][Full Text] [Related]
8. Involvement of CD26 in Differentiation and Functions of Th1 and Th17 Subpopulations of T Lymphocytes.
Zhao X; Wang W; Zhang K; Yang J; Fuchs H; Fan H
J Immunol Res; 2021; 2021():6671410. PubMed ID: 33542930
[TBL] [Abstract][Full Text] [Related]
9. CD26-mediated co-stimulation in human CD8(+) T cells provokes effector function via pro-inflammatory cytokine production.
Hatano R; Ohnuma K; Yamamoto J; Dang NH; Morimoto C
Immunology; 2013 Feb; 138(2):165-72. PubMed ID: 23113658
[TBL] [Abstract][Full Text] [Related]
10. Dipeptidyl peptidase IV (CD26) activity in human alloreactive T cell subsets varies with the stage of differentiation and activation status.
Ruiz P; Hao L; Zucker K; Zacharievich N; Viciana AL; Shenkin M; Miller J
Transpl Immunol; 1997 Jun; 5(2):152-61. PubMed ID: 9269038
[TBL] [Abstract][Full Text] [Related]
11. The CD4+CD26- T-cell population in classical Hodgkin's lymphoma displays a distinctive regulatory T-cell profile.
Ma Y; Visser L; Blokzijl T; Harms G; Atayar C; Poppema S; van den Berg A
Lab Invest; 2008 May; 88(5):482-90. PubMed ID: 18362907
[TBL] [Abstract][Full Text] [Related]
12. Do the molecules CD26 and lymphocytes activation gene-3 differentiate between type 1 and 2 T cell response?
Rogala B; Glück J; Mazur B
J Investig Allergol Clin Immunol; 2002; 12(3):198-203. PubMed ID: 12530119
[TBL] [Abstract][Full Text] [Related]
13. T cells expressing CD26-specific chimeric antigen receptors exhibit extensive self-antigen-driven fratricide.
Zhou S; Zhu X; Shen N; Li Q; Wang N; You Y; Zhong Z; Cheng F; Zou P; Zhu X
Immunopharmacol Immunotoxicol; 2019 Aug; 41(4):490-496. PubMed ID: 31303072
[No Abstract] [Full Text] [Related]
14. Expansion of different subpopulations of CD26
Nieto-Fontarigo JJ; Salgado FJ; San-José ME; Cruz MJ; Valdés L; Pérez-Díaz A; Arias P; Nogueira M; González-Barcala FJ
Sci Rep; 2019 May; 9(1):7556. PubMed ID: 31101830
[TBL] [Abstract][Full Text] [Related]
15. CD26 Expression on T Helper Populations and sCD26 Serum Levels in Patients with Rheumatoid Arthritis.
Cordero OJ; Varela-Calviño R; López-González T; Calviño-Sampedro C; Viñuela JE; Mouriño C; Hernández-Rodríguez Í; Rodríguez-López M; Aspe de la Iglesia B; Pego-Reigosa JM
PLoS One; 2015; 10(7):e0131992. PubMed ID: 26177310
[TBL] [Abstract][Full Text] [Related]
16. Costimulation of CD4+ and CD8+ T cells through CD26: the ADA-binding epitope is not essential for complete signaling.
De Meester IA; Kestens LL; Vanham GL; Vanhoof GC; Vingerhoets JH; Gigase PL; Scharpé SL
J Leukoc Biol; 1995 Sep; 58(3):325-30. PubMed ID: 7665988
[TBL] [Abstract][Full Text] [Related]
17. Multicolor cytoenzymatic evaluation of dipeptidyl peptidase IV (CD26) function in normal and neoplastic human T-lymphocyte populations.
Ruiz P; Zacharievich N; Shenkin M
Clin Diagn Lab Immunol; 1998 May; 5(3):362-8. PubMed ID: 9605992
[TBL] [Abstract][Full Text] [Related]
18. Decreased Frequency and Secretion of CD26 Promotes Disease Progression in Indian Post Kala-azar Dermal Leishmaniasis.
Mukherjee S; Mukhopadhyay D; Ghosh S; Barbhuiya JN; Das NK; Chatterjee M
J Clin Immunol; 2016 Jan; 36(1):85-94. PubMed ID: 26644312
[TBL] [Abstract][Full Text] [Related]
19. The role of tumor cells in the modification of T lymphocytes activity--the expression of the early CD69+, CD71+ and the late CD25+, CD26+, HLA/DR+ activation markers on T CD4+ and CD8+ cells in squamous cell laryngeal carcinoma. Part I.
Starska K; Głowacka E; Kulig A; Lewy-Trenda I; Bryś M; Lewkowicz P
Folia Histochem Cytobiol; 2011; 49(4):579-92. PubMed ID: 22252752
[TBL] [Abstract][Full Text] [Related]
20. Sitagliptin inhibit human lymphocytes proliferation and Th1/Th17 differentiation in vitro.
Pinheiro MM; Stoppa CL; Valduga CJ; Okuyama CE; Gorjão R; Pereira RM; Diniz SN
Eur J Pharm Sci; 2017 Mar; 100():17-24. PubMed ID: 28065853
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
